NASDAQ: INSM
Insmed Inc Stock Ownership - Who owns Insmed?

Insider buying vs selling

Have Insmed Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
William LewisChair and CEO2026-01-202,229$159.85
$356.31kSell
William LewisChair and CEO2026-01-201,006$156.80
$157.74kSell
William LewisChair and CEO2026-01-206,259$30.46
$190.65kBuy
William LewisChair and CEO2026-01-204,440$17.16
$76.19kBuy
William LewisChair and CEO2026-01-201,243$158.37
$196.85kSell
William LewisChair and CEO2026-01-20254$160.70
$40.82kSell
William LewisChair and CEO2026-01-205,967$158.99
$948.69kSell
William LewisChair and CEO2026-01-12297$171.31
$50.88kSell
William LewisChair and CEO2026-01-12297$172.36
$51.19kSell
William LewisChair and CEO2026-01-12315$174.86
$55.08kSell

1 of 32

INSM insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when INSM insiders and whales buy or sell their stock.

INSM Shareholders

What type of owners hold Insmed Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Jpmorgan Chase Co10.81%23,047,676$3.62BInstitution
Richard S. Kollender10.28%21,924,540$3.44BInsider
Darwin Global Management Ltd9.59%20,457,445$3.21BInstitution
Vanguard Group Inc9.35%19,935,820$3.13BInstitution
Blackrock Inc5.80%12,364,904$1.94BInstitution
Fmr LLC4.30%9,180,963$1.44BInstitution
Capital International Investors3.54%7,553,853$1.18BInstitution
Price T Rowe Associates Inc3.25%6,931,466$1.09BInstitution
Baker Bros Advisors LP3.14%6,703,484$1.05BInstitution
D E Shaw Co Inc2.65%5,657,464$887.49MInstitution

1 of 3

INSM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
INSM84.89%15.11%Net SellingNet Selling
ONC2.29%32.05%Net BuyingNet Selling
BNTX20.98%0.00%
RPRX56.76%17.29%Net SellingNet Selling
ALNY82.79%17.21%Net SellingNet Selling

Insmed Stock Ownership FAQ

Who owns Insmed?

Insmed (NASDAQ: INSM) is owned by 98.86% institutional shareholders, 17.59% Insmed insiders, and 0.00% retail investors. Richard S. Kollender is the largest individual Insmed shareholder, owning 21.92M shares representing 10.28% of the company. Richard S. Kollender's Insmed shares are currently valued at $3.44B.

If you're new to stock investing, here's how to buy Insmed stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.